Metropolitan Life Insurance Co NY decreased its stake in shares of John Bean Technologies Corp (NYSE:JBT) by 1.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,006 shares of the industrial products company’s stock after selling 189 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in John Bean Technologies were worth $919,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio lifted its holdings in John Bean Technologies by 62.3% during the fourth quarter. Public Employees Retirement System of Ohio now owns 357 shares of the industrial products company’s stock valued at $26,000 after purchasing an additional 137 shares in the last quarter. Quantamental Technologies LLC acquired a new stake in John Bean Technologies during the first quarter worth about $81,000. Advisor Group Inc. increased its position in John Bean Technologies by 18.2% during the fourth quarter. Advisor Group Inc. now owns 1,421 shares of the industrial products company’s stock worth $102,000 after purchasing an additional 219 shares during the last quarter. Parallel Advisors LLC increased its position in John Bean Technologies by 7.3% during the first quarter. Parallel Advisors LLC now owns 1,520 shares of the industrial products company’s stock worth $140,000 after purchasing an additional 103 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in John Bean Technologies by 26.0% during the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,198 shares of the industrial products company’s stock worth $153,000 after purchasing an additional 453 shares during the last quarter.
In other John Bean Technologies news, Director Caroline Maury Devine sold 300 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $114.30, for a total transaction of $34,290.00. Following the sale, the director now directly owns 50,246 shares in the company, valued at approximately $5,743,117.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP James L. Marvin sold 1,500 shares of the business’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $122.48, for a total transaction of $183,720.00. Following the sale, the executive vice president now owns 19,813 shares in the company, valued at $2,426,696.24. The disclosure for this sale can be found here. Insiders own 2.23% of the company’s stock.
John Bean Technologies (NYSE:JBT) last announced its earnings results on Monday, April 29th. The industrial products company reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.31. The business had revenue of $417.50 million for the quarter, compared to analysts’ expectations of $390.44 million. John Bean Technologies had a net margin of 6.36% and a return on equity of 34.12%. The company’s quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.34 EPS. As a group, sell-side analysts predict that John Bean Technologies Corp will post 4.53 EPS for the current year.
Several equities research analysts recently issued reports on the stock. ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. Wellington Shields lowered shares of John Bean Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, April 30th. Zacks Investment Research lowered shares of W. R. Grace & Co from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Finally, Wells Fargo & Co lowered their target price on shares of WellCare Health Plans from $346.00 to $330.00 and set an “outperform” rating for the company in a research note on Wednesday, May 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $103.60.
John Bean Technologies Company Profile
John Bean Technologies Corporation provides technology solutions to food and beverage industry and equipment and services to air transportation industries. The company operates through JBT FoodTech and JBT AeroTech segments. It provides chilling, mixing/grinding, injecting, marinating, tumbling, portioning, packaging, coating, frying, freezing, weighing, X-ray food inspection, and packaging systems for poultry, beef, pork, and seafood, as well as ready-to-eat meals, fruits, vegetables, dairy, and bakery products; solutions to extract, concentrate, and aseptically process citrus, tomato and other fruits, vegetables, and juices; and solutions for the filling, closing, and preservation of fruits, vegetables, soups, sauces, and dairy and pet food products, as well as ready-to-eat meals.
Featured Article: Hold Rating
Receive News & Ratings for John Bean Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Bean Technologies and related companies with MarketBeat.com's FREE daily email newsletter.